Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.141 CHF
503.14 M CHF
3.11 B CHF
189.56 M
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Founded
1991
FIGI
BBG00LVDL5R6
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ICY is featured.
Frequently Asked Questions
The current price of ICY is 65.594 CHF — it has increased by 4.56% in the past 24 hours. Watch INCYTE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange INCYTE CORPORATION stocks are traded under the ticker ICY.
We've gathered analysts' opinions on INCYTE CORPORATION future price: according to them, ICY price has a max estimate of 90.15 CHF and a min estimate of 46.88 CHF. Watch ICY chart and read a more detailed INCYTE CORPORATION stock forecast: see what analysts think of INCYTE CORPORATION and suggest that you do with its stocks.
ICY stock is 4.36% volatile and has beta coefficient of 0.73. Track INCYTE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is INCYTE CORPORATION there?
Today INCYTE CORPORATION has the market capitalization of 12.11 B, it has decreased by −0.95% over the last week.
Yes, you can track INCYTE CORPORATION financials in yearly and quarterly reports right on TradingView.
INCYTE CORPORATION is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ICY earnings for the last quarter are 0.91 CHF per share, whereas the estimation was 0.89 CHF resulting in a 1.79% surprise. The estimated earnings for the next quarter are 1.36 CHF per share. See more details about INCYTE CORPORATION earnings.
INCYTE CORPORATION revenue for the last quarter amounts to 964.26 M CHF, despite the estimated figure of 913.77 M CHF. In the next quarter, revenue is expected to reach 1.03 B CHF.
ICY net income for the last quarter is 90.21 M CHF, while the quarter before that showed −399.71 M CHF of net income which accounts for 122.57% change. Track more INCYTE CORPORATION financial stats to get the full picture.
No, ICY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 2.52 K employees. See our rating of the largest employees — is INCYTE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE CORPORATION EBITDA is 64.56 M CHF, and current EBITDA margin is 19.87%. See more stats in INCYTE CORPORATION financial statements.
Like other stocks, ICY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.